Compare IDYA & ALG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IDYA | ALG |
|---|---|---|
| Founded | 2015 | 1955 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.1B |
| IPO Year | 2019 | 1996 |
| Metric | IDYA | ALG |
|---|---|---|
| Price | $28.22 | $150.48 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 16 | 3 |
| Target Price | $52.86 | ★ $225.00 |
| AVG Volume (30 Days) | ★ 676.7K | 196.8K |
| Earning Date | 05-06-2026 | 05-04-2026 |
| Dividend Yield | N/A | ★ 0.81% |
| EPS Growth | ★ 61.90 | N/A |
| EPS | N/A | ★ 2.41 |
| Revenue | $218,710,000.00 | ★ $1,603,715,000.00 |
| Revenue This Year | N/A | $5.26 |
| Revenue Next Year | $201.05 | $3.97 |
| P/E Ratio | ★ N/A | $63.39 |
| Revenue Growth | ★ 3024.43 | N/A |
| 52 Week Low | $20.47 | $145.76 |
| 52 Week High | $39.28 | $233.29 |
| Indicator | IDYA | ALG |
|---|---|---|
| Relative Strength Index (RSI) | 41.29 | 38.55 |
| Support Level | $27.66 | $145.76 |
| Resistance Level | $29.74 | $156.54 |
| Average True Range (ATR) | 1.05 | 4.78 |
| MACD | 0.04 | 0.50 |
| Stochastic Oscillator | 22.94 | 37.38 |
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275 (Werner Helicase), IDE161 (PARG), and IDE705 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.
Alamo Group Inc is engaged in the design, manufacture, and servicing of high-quality vegetation management and infrastructure maintenance equipment for governmental, industrial, and agricultural use. Its products include agricultural implements, tree and branch chippers, forestry/wood recycling equipment, street and parking lot sweepers, leaf and debris collection equipment, truck-mounted highway attenuator trucks, vacuum trucks, hydro-excavation equipment, telescopic boom excavators, snow removal equipment, etc. The company's reportable segments are Vegetation Management, which generates the maximum revenue, and Industrial Equipment. Geographically, the company generates maximum revenue from the United States, followed by Canada, France, the UK, Brazil, the Netherlands, and other regions.